Showing results (11-20 of 101) with videos related to
Sort By:
Pageof 11
The Annals of Pharmacotherapy|October 31, 2000
Detrimental effects of high-dose dexamethasone in severe, refractory, HIV-related thrombocytopeniaM Marroni, P GreselePostgraduate Medical Journal|December 1, 1980
Mucus-secreting 'signet-ring' cells in CSF revealing the site of primary cancerG Agnelli, P GreseleBiochemical Pharmacology|June 8, 2019
Nitric oxide-enhancing or -releasing agents as antithrombotic drugsP Gresele, S Momi, G GuglielminiThe Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulationR Vezza, G G Nenci, P GreseleDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2003
NCX4016: a novel antithrombotic agentP Gresele, S Momi, A M MezzasomaBiochemical Pharmacology|July 1, 1984
Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2P Gresele, H Deckmyn, E Huybrechts, et al.Thrombosis and Haemostasis|February 28, 1986
Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activityP Gresele, J Arnout, H Deckmyn, et al.Cancer Metastasis Reviews|July 15, 2017
Platelet-targeted pharmacologic treatments as anti-cancer therapyP Gresele, S Momi, M Malvestiti, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1988
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonrespondersP Gresele, D Blockmans, H Deckmyn, et al.Pharmatherapeutica|January 1, 1981
Effect of pentoxifylline on platelet aggregationG G Nenci, P Gresele, G Agnelli, et al.Pageof 11